Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers

NCT03694912 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03694912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03694912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2018
Completion date
September 22, 2023
Enrollment
426 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear renal cell cancer (< 7cm size)